Search
Now showing items 1-8 of 8
Current controversies in trichology: a European expert consensus statement
(John Wiley & Sons, 2021)
Introduction: Hair disorders are one of the most common conditions within dermatology practice but, although new diagnostic tools and therapeutic options have arisen, the management of these patients ...
Platelet-rich plasma and its use for cicatricial and non-cicatricial alopecias: a narrative review
(Springer, 2020-06)
The concept and description of platelet-rich plasma (PRP) started in the field of hematology and is being extensively used in other fields of medicine. Interest in the application of PRP has been ...
The dermoscopic “chromosome arms sign” for terra firma-forme dermatosis
(Openventio Publishers, 2021)
Introduction: Terra firma-forme dermatosis (TFFD) belongs to the group of “dirty dermatoses” and represents a not well-known and surely underestimated skin condition. Clinical cases: We present 2 cases ...
Ozenoxacin, a new effective and safe topical treatment for impetigo in children and adolescents
(Karger, 2020)
Background: Ozenoxacin is a topical antibiotic approved in Europe to treat non-bullous impetigo in adults and children aged ≥6 months. This analysis evaluated the efficacy and safety of ozenoxacin in ...
Tricholeichomania by proxy
(Athenaeum Scientific Publishers, 2020)
La queratodermia acuagénica: actualización terapéutica
(Elsevier, 2021)
La queratodermia acuagénica (QA) es una afectación dermatológica adquirida poco frecuente que se caracteriza por la aparición de edema y pápulas blanquecinas-translúcidas desencadenado por la inmersión ...
Trichodynia and telogen effluvium in COVID-19 patients: results of an international expert opinion survey on diagnosis and management
(Elsevier, 2021)
Background: The cutaneous manifestations of COVID-19 may be useful disease markers and prognostic indicators. Recently, postinfectious telogen effluvium and trichodynia have also been reported. Objective: ...
Automatic SCOring of atopic dermatitis using deep learning (ASCORAD): a pilot study
(Elsevier, 2022)
Atopic dermatitis (AD) is a chronic, itchy skin condition that affects 15–20% of children, but may occur at any age. It is estimated that 16.5 million U.S. adults (7.3%) have AD that initially began at ...